Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of C-reactive protein as a prognostic marker in COVID-19.
Stringer D, Braude P, Myint PK, Evans L, Collins JT, Verduri A, Quinn TJ, Vilches-Moraga A, Stechman MJ, Pearce L, Moug S, McCarthy K, Hewitt J, Carter B; COPE Study Collaborators. Stringer D, et al. Int J Epidemiol. 2021 May 17;50(2):420-429. doi: 10.1093/ije/dyab012. Int J Epidemiol. 2021. PMID: 33683344 Free PMC article.
Update to the study protocol, including statistical analysis plan, for the multicentre, randomised controlled OuTSMART trial: a combined screening/treatment programme to prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies.
Stringer D, Gardner LM, Peacock JL, Rebollo-Mesa I, Hilton R, Shaw O, Baker R, Clark B, Thuraisingham RC, Buckland M, Picton M, Worthington J, Borrows R, Briggs D, Shah S, Shiu KY, McCullough K, Phanish M, Hegarty J, Stoves J, Ahmed A, Ayub W, Horne R, McCrone P, Kelly J, Murphy C, Dorling A. Stringer D, et al. Trials. 2019 Aug 5;20(1):476. doi: 10.1186/s13063-019-3602-2. Trials. 2019. PMID: 31383029 Free PMC article.
The efficacy of real versus sham external Trigeminal Nerve Stimulation (eTNS) in youth with Attention-Deficit/Hyperactivity Disorder (ADHD) over 4 weeks: a protocol for a multi-centre, double-blind, randomized, parallel-group, phase IIb study (ATTENS).
Rubia K, Johansson L, Carter B, Stringer D, Santosh P, Mehta MA, Conti AA, Bozhilova N, Eraydin IE, Cortese S. Rubia K, et al. Among authors: stringer d. BMC Psychiatry. 2024 Apr 30;24(1):326. doi: 10.1186/s12888-024-05650-1. BMC Psychiatry. 2024. PMID: 38689273 Free PMC article.
Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trial.
Stringer D, Gardner L, Shaw O, Clarke B, Briggs D, Worthington J, Buckland M, Danzi G, Hilton R, Picton M, Thuraisingham R, Borrows R, Baker R, McCullough K, Stoves J, Phanish M, Shah S, Shiu KY, Walsh SB, Ahmed A, Ayub W, Hegarty J, Tinch-Taylor R, Georgiou E, Bidad N, Kılıç A, Moon Z, Horne R, McCrone P, Kelly J, Murphy C, Peacock J, Dorling A. Stringer D, et al. EClinicalMedicine. 2023 Jan 12;56:101819. doi: 10.1016/j.eclinm.2022.101819. eCollection 2023 Feb. EClinicalMedicine. 2023. PMID: 36684392 Free PMC article.
Olanzapine for young PEople with aNorexia nervosa (OPEN): A protocol for an open-label feasibility study.
Said O, Sengun Filiz E, Stringer D, Applewhite B, Kellermann V, Mutwalli H, Bektas S, Akkese MN, Kumar A, Carter B, Simic M, Sually D, Bentley J, Young AH, Madden S, Byford S, Landau S, Lawrence V, Treasure J, Schmidt U, Nicholls D, Himmerich H. Said O, et al. Among authors: stringer d. Eur Eat Disord Rev. 2024 May;32(3):532-546. doi: 10.1002/erv.3060. Epub 2024 Feb 1. Eur Eat Disord Rev. 2024. PMID: 38299859
The CIRCuiTS study (Implementation of cognitive remediation in early intervention services): protocol for a randomised controlled trial.
Wykes T, Joyce E, Velikonja T, Watson A, Aarons G, Birchwood M, Cella M, Dopson S, Fowler D, Greenwood K, Johnson S, McCrone P, Perez J, Pickles A, Reeder C, Rose D, Singh S, Stringer D, Taylor M, Taylor R, Upthegrove R. Wykes T, et al. Among authors: stringer d. Trials. 2018 Mar 15;19(1):183. doi: 10.1186/s13063-018-2553-3. Trials. 2018. PMID: 29544551 Free PMC article.
Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial.
Gaughran F, Stringer D, Berk M, Smith S, Taylor D, Whiskey E, Landau S, Murray R, McGuire P, Gardner-Sood P, Wojewodka G, Ciufolini S, Jordan H, Clarke J, Allen L, Krivoy A, Stubbs B, Lowe P, Arbuthnott M, Rathod S, Boardman A, Firdosi M, McGrath JJ. Gaughran F, et al. Among authors: stringer d. Trials. 2020 Jan 6;21(1):14. doi: 10.1186/s13063-019-3758-9. Trials. 2020. PMID: 31907006 Free PMC article.
Effect of Optimized Immunosuppression (Including Rituximab) on Anti-Donor Alloresponses in Patients With Chronically Rejecting Renal Allografts.
Shiu KY, Stringer D, McLaughlin L, Shaw O, Brookes P, Burton H, Wilkinson H, Douthwaite H, Tsui TL, Mclean A, Hilton R, Griffin S, Geddes C, Ball S, Baker R, Roufosse C, Horsfield C, Dorling A. Shiu KY, et al. Among authors: stringer d. Front Immunol. 2020 Feb 5;11:79. doi: 10.3389/fimmu.2020.00079. eCollection 2020. Front Immunol. 2020. PMID: 32117242 Free PMC article. Clinical Trial.
221 results